Skip to content

Clinical trials

Completed Phase 2/3 Dermatomyositis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatomyositis Phase: Phase 2/3 Status: Completed Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20071
20141
20151
20171
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Karolinska Institutet2
Boston Children's Hospital1
National Institute of Environmental Health Sciences (NIEHS)1
Northwell Health1
Royal Brompton & Harefield NHS Foundation Trust1
Tokyo Medical and Dental University1
argenx1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatomyositis8
Polymyositis6
Myositis5
Lung Diseases, Interstitial2
Mixed Connective Tissue Disease2
Myositis, Inclusion Body2
Arthritis, Juvenile1
Calcinosis1
Connective Tissue Diseases1
Crohn Disease1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.